Laboratory Monitoring for Low-Dose Cephalexin (Keflex)
For typical adults on low-dose cephalexin, routine laboratory monitoring is generally not required.
Baseline Assessment
Before initiating cephalexin therapy, consider obtaining:
- Renal function (serum creatinine or creatinine clearance) if the patient has known or suspected renal impairment, is elderly, or will receive prolonged therapy 1
- Prothrombin time (PT) only if the patient has risk factors: renal/hepatic impairment, poor nutritional state, protracted antimicrobial therapy course, or is on anticoagulant therapy 1
The FDA label specifically notes that cephalexin "should be administered with caution in the presence of markedly impaired renal function" and that "careful clinical observation and laboratory studies should be made" in such cases 1.
Ongoing Monitoring
For most patients on standard short courses: No routine laboratory monitoring is needed.
Monitor renal function periodically if:
- Baseline renal impairment exists (creatinine clearance <30 mL/min requires dose adjustment) 2, 3, 4
- Patient is elderly (more likely to have decreased renal function) 1
- Prolonged therapy is planned (>2-4 weeks)
- Patient is on metformin (cephalexin increases metformin levels by 24-34%) 1
Monitor PT/INR if:
- Patient is on warfarin or other anticoagulants
- Patient has hepatic impairment, malnutrition, or is receiving protracted therapy 1
Special Considerations
Positive Coombs' test: Cephalosporins can cause false-positive direct Coombs' tests 1. This is clinically relevant during:
- Hematologic studies
- Transfusion cross-matching procedures
- Coombs' testing of newborns whose mothers received cephalosporins before delivery
This is typically a non-immunological phenomenon and does not require routine monitoring unless transfusion or hemolytic concerns arise 5.
Urine glucose testing: Cephalexin can cause false-positive reactions for glucose with Benedict's and Fehling's solutions and Clinitest® tablets 1. This does not require monitoring but should be considered when interpreting results.
Clinical Monitoring Priority
The most important monitoring is clinical, not laboratory-based:
- Watch for allergic reactions (discontinue immediately if they occur)
- Monitor for superinfection with prolonged use
- Assess for Clostridioides difficile infection if diarrhea develops (can occur up to 2+ months after therapy) 1
The evidence consistently shows that for patients with normal renal function on standard short courses of cephalexin, laboratory monitoring beyond baseline assessment (if indicated) is unnecessary 6, 1.